Thus, widespread CSNK2 dysregulation, combined with data from prior studies that overexpression of CSNK2A1 can lead to in vivo oncogenic transformation [48–50], strongly suggests an important role in cancer. The gene discussed is CSNK2A1; the disease is cancer.